S Ballou1, L Keefer2. 1. Division of Gastroenterology, Beth Israel Deaconess Medical Center, Boston, MA, USA. 2. Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Abstract
BACKGROUND: Despite the well-documented economic and psychosocial burden of irritable bowel syndrome (IBS), few studies have focused on the impact of IBS on daily activities. This study aims to quantitate impairment in daily activities among IBS patients and to evaluate the relationship between impairment, IBS, quality of life, and psychiatric symptoms. METHODS: A total of 179 participants meeting ROME-III criteria for IBS completed an online research survey evaluating the following variables: (i) the impact of IBS on daily activities, (ii) comorbid psychiatric diagnoses, (iii) symptom severity, (iv) quality of life, and (v) symptom-specific cognitive affective factors related to IBS. KEY RESULTS: This sample reported a high degree of impairment due to IBS, with 76% of the sample reporting some degree of IBS-related impairment in at least five different domains of daily life. Rates of impairment were significantly higher for participants who met criteria for anxiety, depression, and/or panic disorder. CONCLUSIONS & INFERENCES: This study contributes to existing literature by demonstrating a high level of daily impairment among patients with IBS, particularly those who meet criteria for anxiety, depression, and panic disorder. These findings support the importance of integrated psychosocial and medical care for IBS patients, and highlight the utility of evaluation and intervention for behavioral avoidance/impairment especially among those who exhibit signs or symptoms of psychiatric diagnoses.
BACKGROUND: Despite the well-documented economic and psychosocial burden of irritable bowel syndrome (IBS), few studies have focused on the impact of IBS on daily activities. This study aims to quantitate impairment in daily activities among IBSpatients and to evaluate the relationship between impairment, IBS, quality of life, and psychiatric symptoms. METHODS: A total of 179 participants meeting ROME-III criteria for IBS completed an online research survey evaluating the following variables: (i) the impact of IBS on daily activities, (ii) comorbid psychiatric diagnoses, (iii) symptom severity, (iv) quality of life, and (v) symptom-specific cognitive affective factors related to IBS. KEY RESULTS: This sample reported a high degree of impairment due to IBS, with 76% of the sample reporting some degree of IBS-related impairment in at least five different domains of daily life. Rates of impairment were significantly higher for participants who met criteria for anxiety, depression, and/or panic disorder. CONCLUSIONS & INFERENCES: This study contributes to existing literature by demonstrating a high level of daily impairment among patients with IBS, particularly those who meet criteria for anxiety, depression, and panic disorder. These findings support the importance of integrated psychosocial and medical care for IBSpatients, and highlight the utility of evaluation and intervention for behavioral avoidance/impairment especially among those who exhibit signs or symptoms of psychiatric diagnoses.
Authors: J S Labus; R Bolus; L Chang; I Wiklund; J Naesdal; E A Mayer; B D Naliboff Journal: Aliment Pharmacol Ther Date: 2004-07-01 Impact factor: 8.171
Authors: Ya-Chen Tina Shih; Victoria E Barghout; Robert S Sandler; Priti Jhingran; Medha Sasane; Suzanne Cook; David C Gibbons; Michael Halpern Journal: Dig Dis Sci Date: 2002-08 Impact factor: 3.199
Authors: Bernd Löwe; Kerstin Gräfe; Stephan Zipfel; Robert L Spitzer; Christoph Herrmann-Lingen; Steffen Witte; Wolfgang Herzog Journal: J Psychosom Res Date: 2003-12 Impact factor: 3.006
Authors: Gillian Eleanor Cassar; George Youssef J; Simon R Knowles; Richard Moulding; David Austin Journal: Turk J Gastroenterol Date: 2021-10 Impact factor: 1.555
Authors: John S Kane; Andrew J Irvine; Yannick Derwa; Olorunda Rotimi; Alexander C Ford Journal: Therap Adv Gastroenterol Date: 2018-06-21 Impact factor: 4.409
Authors: Lisa Vork; Zlatan Mujagic; Marjan Drukker; Daniel Keszthelyi; José M Conchillo; Martine A M Hesselink; Jim van Os; Ad A M Masclee; Carsten Leue; Joanna W Kruimel Journal: Neurogastroenterol Motil Date: 2018-11-20 Impact factor: 3.598
Authors: Filipa Sampaio; Marianne Bonnert; Ola Olén; Erik Hedman; Maria Lalouni; Fabian Lenhard; Brjánn Ljótsson; Richard Ssegonja; Eva Serlachius; Inna Feldman Journal: BMJ Open Date: 2019-01-24 Impact factor: 2.692